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ABSTRACT: The structurally related exocyclic guanine adducts
α-hydroxypropano-dG (α-OH-PdG), γ-hydroxypropano-dG (γ-
OH-PdG), and M1dG are formed when DNA is exposed to the
reactive aldehydes acrolein and malondialdehyde (MDA). These
lesions are believed to form the basis for the observed cytotoxicity
and mutagenicity of acrolein and MDA. In an eﬀort to understand
the enzymatic pathways and chemical mechanisms that are
involved in the repair of acrolein- and MDA-induced DNA
damage, we investigated the ability of the DNA repair enzyme
AlkB, an α-ketoglutarate/Fe(II) dependent dioxygenase, to
process α-OH-PdG, γ-OH-PdG, and M1dG in both single- and
double-stranded DNA contexts. By monitoring the repair
reactions using quadrupole time-of-ﬂight (Q-TOF) mass
spectrometry, it was established that AlkB can oxidatively dealkylate γ-OH-PdG most eﬃciently, followed by M1dG and α-
OH-PdG. The AlkB repair mechanism involved multiple intermediates and complex, overlapping repair pathways. For example,
the three exocyclic guanine adducts were shown to be in equilibrium with open-ring aldehydic forms, which were trapped using
(pentaﬂuorobenzyl)hydroxylamine (PFBHA) or NaBH4. AlkB repaired the trapped open-ring form of γ-OH-PdG but not the
trapped open-ring of α-OH-PdG. Taken together, this study provides a detailed mechanism by which three-carbon bridge
exocyclic guanine adducts can be processed by AlkB and suggests an important role for the AlkB family of dioxygenases in
protecting against the deleterious biological consequences of acrolein and MDA.
■ INTRODUCTION
Reactive aldehydes, such as acrolein and malondialdehyde
(MDA), react with DNA and form exocyclic adducts. Acrolein,
an α,β-unsaturated aldehyde commonly found in tobacco
smoke1 and other exogenous sources (petroleum industry
waste,2 automobile exhaust,3,4 and overcooked food5) is a
mutagenic agent6−10 that has been implicated in the etiology of
lung cancer.11,12 Acrolein is also formed endogenously as a
byproduct of lipid peroxidation,13,14 alongside structurally
related molecules such as MDA. As a reactive aldehyde,
acrolein condenses with deoxyguanosine (dG) through a
Michael addition and subsequent cyclization15−17 to form two
exocyclic adducts: α-OH-PdG (3-(2′-deoxy-β-D-erythro-pento-
furanosyl)-5,6,7,8-tetrahydro-6-hydroxypyrimido[1,2-α]purin-
10(3H)-one) and γ-OH-PdG (3-(2′-deoxy-β-D-erythro-pento-
furanosyl)-5,6,7,8-tetrahydro-8-hydroxypyrimido[1,2-α]purin-
10(3H)-one) (Figure 1).
The acrolein−DNA adducts have deleterious biological
consequences and are believed to underlie the mutagenic
eﬀects of acrolein18−21 and its ability to promote carcino-
genesis.22,23 α-OH-PdG can block DNA replication in human
cells and can cause G to A and G to T mutations.24,25 By
contrast, γ-OH-PdG is eﬃciently bypassed by certain
polymerases in both bacterial and mammalian cells;26−29
however, γ-OH-PdG can also form inter- and intrastrand
cross-links30−33 (via an open-ring aldehydic form), which are
diﬃcult to bypass and can cause mutations.34−36
MDA is an important biomarker of lipid peroxidation, a
deleterious reaction between cellular lipids and reactive oxygen
species produced by inﬂammatory processes.13,14,37 Similar to
acrolein, MDA can also form an exocyclic dG adduct, M1dG (3-
(2′-deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-α]purin-
10(3H)-one).38 This adduct is both a strong block to
replication and mutagenic,39−41 properties that may contribute
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to inﬂammation-associated human malignancies, including
aging42 and cancer.13,37
Given the toxicity and mutagenicity of the acrolein- and
MDA-derived exocyclic deoxyguanosine adducts, it is important
to investigate if these adducts are substrates for DNA repair
pathways. While the nucleotide excision repair (NER) pathway
can remove these lesions from DNA,23 acrolein, the agent
responsible for generating the exocyclic dG lesions, inhibits
NER.23 Little is known about the contribution of a direct
reversal repair pathway for removal of acrolein- and MDA-
derived exocyclic guanine DNA adducts.
AlkB, the Escherichia coli direct reversal DNA repair enzyme,
can eﬃciently repair a wide range of DNA and RNA alkyl
lesions.43−53 As an Fe(II)- and α-ketoglutarate-dependent
dioxygenase, AlkB uses molecular oxygen to oxidize and
remove simple alkyl DNA lesions (such as 3-methylcytosine,51
1-methyladenine,51 3-methylthymine,51 6-methyladenine,50 1-
methylguanine (m1G),51 2-methylguanine(m2G),52 and 2-
ethylguanine(e2G)52) and exocyclic bridged lesions (N1,N6-
ethenoadenine (εA),46,47 N1,N6-ethanoadenine (EA),49,50 3,N4-
ethenocytosine (εC),46,48 hydroxy-3,N4-ethanocytosine,48,53
and hydroxy-3,N4-propanocytosine).48,53 Given the ability of
AlkB to remove alkyl groups from both N151 and N2
positions52 of guanine, we suspected that the exocyclic guanine
adducts α-OH-PdG, γ-OH-PdG, and M1dG could also be
potential substrates for AlkB.
This study investigated the ability of AlkB to repair the
acrolein- and MDA-derived exocyclic dG lesions in single-
straned (ssDNA) or double-stranded DNA (dsDNA). We
established that all three exocyclic dG lesions can exist in open-
ring forms in the sequence context studied, and we also
investigated whether these open-ring forms are substrates for
AlkB repair. Using high-resolution quadrupole time-of-ﬂight
(Q-TOF) MS, we found that AlkB can oxidize all three
exocyclic dG adducts, in both the open- and closed-ring forms.
The AlkB activity on the lesions was more eﬃcient in ssDNA
than in dsDNA, with the base opposite the lesion dictating the
repair eﬃciency. Among the three lesions studied, γ-OH-PdG
was most eﬃciently repaired, followed by M1dG and α-OH-
PdG, respectively. By identifying and characterizing the AlkB
reaction intermediates and products using MS, MS/MS, and
biochemical trapping experiments, a model for the chemical
mechanism of repair of exocyclic dG lesions by AlkB is
proposed. The observation that these important lesions are
oxidized by AlkB provides evidence that direct reversal
enzymes, such as AlkB, may play important roles as modulators
of the biological consequences of acrolein and MDA.
■ EXPERIMENTAL PROCEDURES
Oligonucleotide Synthesis. Oligonucleotide 16-mers of se-
quence 5′-GAAGACCTXGGCGTCC-3′ (X = adduct) bearing
exocyclic guanine adducts, α-OH-PdG,54,55 γ-OH-PdG,56,57 and
M1dG
58 (Figure 1) were prepared using the solid-phase methods59
and were deprotected, puriﬁed, and characterized as described
previously. Table 1 shows the calculated MWs of all the
oligonucleotides used in this study and their observed intermediates.
To determine the oligonucleotides’ concentrations, the extinction
coeﬃcients (ε) of normal DNA bases at 260 nm were used; alkyl-
modiﬁed bases were approximated as guanines.
AlkB Repair of Exocyclic dG Lesions (α-OH-PdG, γ-OH-PdG,
and M1dG) in Single- and Double-Stranded DNA Oligonucleo-
tides. AlkB incubations were performed with the AlkBΔN11 protein,
a version of AlkB lacking the ﬁrst 11 amino acids. This truncated
protein has been previously shown to have activity similar to that of
wild-type AlkB.49 The AlkBΔN11 protein was expressed in BL21-
(DE3) cells and puriﬁed as described previously.49 The AlkB
incubations were performed at 37 °C for 2 h in a reaction buﬀer
containing 45 mM HEPES (pH 8.0), 0.9 mM α-ketoglutarate, 67 μM
Fe(NH4)2(SO4)2·6H2O, and 1.8 mM ascorbate, followed by HPLC/
Q-TOF MS analysis. Typically, 100 pmol DNA was reacted with 5 μM
AlkB (or enzyme diluent for control reactions) in the presence of all
cofactors in a 20 μL reaction volume. The AlkB incubations with
double-stranded DNA were performed under similar conditions except
that prior to AlkB addition 1.2 equiv of complementary oligonucleo-
tides were annealed by heating the mixture at 65 °C for 5 min. The
mixtures were cooled at a rate of 0.1 °C/s to 4 °C and then used in
AlkB reactions as described above.
Quantiﬁcation of AlkB Repair Eﬃciency. The AlkB repair
eﬃciencies were estimated from the fraction of starting material
converted into intermediates and products (Table 2). These values
were determined by integrating the extracted ion chromatogram (EIC)
peaks corresponding to each of the species observed in the AlkB
reactions (starting material, intermediates, and products) and
calculating the percentage of each species formed after AlkB
incubation relative to the total amount of material (Table 3). In
each reaction, the total amount of material was calculated by summing
the areas corresponding to the starting material and all intermediates
and products derived from the starting material. All of the values were
background-corrected for the amount of species (intermediate or
Figure 1. Reactions of the environmental pollutant acrolein and of the lipid peroxidation byproduct malondialdehyde with DNA guanine bases
generate the structurally similar exocyclic deoxyguanosine lesions α-OH-PdG, γ-OH-PdG, and M1dG.
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product) that may have been present in the AlkB untreated control
reactions.
Trapping Experiments of DNA Adducts with PFBHA.
Trapping reactions of oligonucleotides with PFBHA were performed
in water at room temperature for 1 h using 5 μM DNA and 500 μM
PFBHA in a 10 μL incubation volume, followed by HPLC/Q-TOF
MS analysis, as described previously.50 The calculated MWs of the
trapped intermediates are included in Table S1.
Melting Temperature Analysis. Melting temperatures were
measured on the dsDNA obtained by mixing the 16-mer
oligonucleotides containing lesions with equimolar amounts of the
complementary oligonucleotides containing each of the four possible
natural bases (C, T, G, and A) opposite the lesion site. The
oligonucleotides (4 μM in a total volume of 25 μL) were mixed in
AlkB reaction buﬀer (45 mM HEPES, pH 8, 0.9 mM α-ketoglutarate,
1.8 mM ascorbate, 67 μM Fe(II)) supplemented with the high-
resolution melting dye LCGreen Plus (Idaho Technologies Inc., Salt
Lake City, UT) to a ﬁnal concentration of 1×. Annealing was done by
heating at 75 °C for 5 min, followed by a slow cooling (0.1 °C/s) to 4
°C. Melting temperature, Tm, was measured using a Roche LightCycler
480 spectrophotometer, by heating the samples from 37 to 95 °C at a
rate of 0.1 °C/s and recording ﬂuorescence ﬁve times every degree
Celsius. Data analysis was performed using LightCycler480 software.
For each oligonucleotide and complement pair, three independent
measurements were performed and averaged.
Reduction of Exocyclic dG Lesions by NaBH4 and Their
Repair by AlkB. Reduction of exocylic dG lesions (α-OH-PdG, γ-
OH-PdG, and M1dG) was performed by incubating ∼1 nmol of 16-
mer oligonucleotide in 100 mM potassium phosphate, pH 8.0, with ∼1
M NaBH4 for 1 h at 37 °C in 10 μL reaction volume. To prevent
excess pressure from hydrogen gas accumulation from the NaBH4
hydrolysis, the tubes were uncapped and continuously spun in a
microfuge during the incubation. Subsequently, the excess NaBH4 and
salts were removed by passing the reaction mixtures through
homemade dry-spun Sephadex G50 Fine (Amersham Biosciences)
columns. After concentration by centrifugation under vacuum, the
puriﬁed reduced oligonucleotides were used in AlkB reactions using
the conditions described previously. All samples (untreated, NaBH4
treated, and NaBH4 then AlkB treated) were analyzed using HPLC-
ESI-TOF mass spectrometry.
HPLC/Q-TOF MS and MS/MS Analysis. Oligonucleotide analyses
were performed using Agilent Q-TOF 6510 mass spectrometer (Palo
Alto, CA) setup as follows: needle voltage, 3.5 kV; nitrogen drying gas,
8 L/min; heated capillary, 340 °C; and nebulizer, 30 psig. The reaction
mixtures were separated by HPLC on a Zorbax SB-Aq column (2.1 ×
150 mm; 3.5 μm; Agilent Technologies, Palo Alto, CA) at a 0.2 mL/
min ﬂow rate at room temperature. Solvents were 10 mM ammonium
acetate in water (A) and 100% acetonitrile (B). A linear gradient of 1−
18% B over 21 min was used. Data analysis was performed using the
Agilent MassHunter workstation software.
LC−MS/MS analyses were performed on the Agilent 6510 Q-TOF
instrument, operated in the negative ion mode with the following
parameters: gas temperature, 340 °C; ESI capillary voltage, 3.5 kV;
Table 1. Calculated and Observed Monoisotopic Molecular
Weights of Oligonucleotides Observed in the Present Study
lesion or base
(structures)
MW (calcd) of
neutral species
calcd monoisotopic
m/z (−4 charge)
obsvd
monoisotopic m/z
(−4 charge)
(1a)/(1b) 4960.88 1239.21 1239.16
1239.19
1239.20
(2)/(18) 4942.87 1234.71 1234.68
1234.70
(3a)/(3b)/
(21)
4976.88 1243.21 1243.17
1243.18
1243.24
(4)/(20) 4958.87 1238.71 1238.67
1238.68
1238.70
(5a)/(5b) 4960.88 1239.21 1239.23
(6) 4904.86 1225.21 1225.17
1225.19
(7) 4940.86 1234.21 1234.17
1234.19
(8) 4956.85 1238.20 1238.19
1238.24
(9)/(13)/(14) 4974.86 1242.71 1242.73
1242.69
(10) 4992.87 1247.21 1247.19
1247.25
(11a)/(11b)/
(12a)/(12b)
4958.87 1238.71 not observed
(15) 4944.89 1235.21 1235.16
(16) 4962.90 1239.72 1239.71
(17) 4978.89 1243.72 1243.71
(19) 4958.68 1239.67 1239.67
Table 2. Percentage of Lesion-Containing Oligonucleotides
Chemically Modiﬁed by AlkB in a 2 h Reaction
X = lesion α-OH-PdG (%) γ-OH-PdG (%) M1dG (%)
ssDNA 8.0 58.8 31.0
dsDNA (T: X) 1.6 17 45.5
dsDNA (G: X) 1.0 10.4 22.0
dsDNA (C: X) 0.6 <0.5 18.1
dsDNA (A: X) 0.7 11.2 15.2
Table 3. Intermediates and Products from the 2 h Incubation
of AlkB with α-OH-PdG (A), γ-OH-PdG (B), and M1dG (C)
(A)
α-OH-PdG
(%) intermediates (%)
product
(%)
X = lesion (α-
OH-PdG)
(1a)/(1b)
1239.20
(2)
1234.70
(3a)/(3b)
1243.18
(4)
1238.68
(6)
1225.20
ssDNA 74.0 18.0 5.5 2.5 <0.1
dsDNA (T: X) 84.4 14.0 1.3 0.3 <0.1
dsDNA (G: X) 84.0 14.9 0.9 0.1 <0.1
dsDNA (C: X) 84.7 14.6 0.3 0.4 <0.1
dsDNA (A: X) 84.2 15.1 0.6 <0.1 <0.1
(B)
γ-OH-PdG
(%) intermediates (%)
product
(%)
X = lesion (γ-
OH-PdG)
(5a)/(5b)
1239.17
(3a)/(3b)
1243.17
(7)
1234.17
(4)
1238.67
(6)
1225.17
ssDNA 41.2 45.0 3.5 1.3 9.0
dsDNA (T: X) 83.0 12.5 2.8 1.0 0.7
dsDNA (G: X) 89.5 9.0 0.7 0.4 0.4
dsDNA (C: X) 99.9 <0.1 <0.1 <0.1 <0.1
dsDNA (A: X) 88.7 8.3 1.9 0.7 0.4
(C)
M1dG
(%) intermediates (%)
product
(%)
X = lesion
(M1dG)
(7)
1234.19
(8)
1238.19
(9)/(13)/
(14) 1242.69
(10)
1247.19
(6)
1225.19
ssDNA 69.0 8.2 6.7 7.9 +8.1
dsDNA (T: X) 54.5 16.7 12.3 11.9 4.6
dsDNA (G: X) 78.0 6.4 5.7 6.1 3.8
dsDNA (C: X) 81.9 7.3 6.9 2.6 1.3
dsDNA (A: X) 84.8 4.4 4.1 3.8 2.9
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nebulizer pressure, 30 psi; drying nitrogen gas, 8 L/min; and
fragmentation energy, 30−35 V. The theoretical fragmentation pattern
of a 16-mer oligonucleotide is shown in Figure 2A; the expected
monoisotopic masses of the fragments were calculated using Mongo
Oligo Mass Calculator, version 2.06 (http://mods.rna.albany.edu/
Masspec-Toolbox). A typical fragmentation spectrum (e.g., inter-
mediate 3a/3b) is shown in Figure 2B. The comparison between the
calculated and observed m/z values for the MS/MS spectrum of 3a/3b
is shown in Figure 2C. MS/MS analyses of the observable reactants,
intermediates, and products for all of the AlkB reactions with 16-mer
oligonucleotides containing α-OH-PdG, γ-OH-PdG, and M1dG are
included in the Supporting Information (Figures S10−S17 and Tables
S2−S9).
■ RESULTS
Exocyclic Guanine DNA Adducts Are Substrates for
AlkB in ssDNA. The ability of AlkB to repair acrolein- and
MDA-derived exocyclic dG adducts was measured by
incubating site-speciﬁcally modiﬁed 16-mer oligonucleotides
with puriﬁed AlkB protein. Following a 2 h incubation at 37 °C,
the reaction mixtures were analyzed using high-resolution
MS.50,52 For each lesion, experiments were conducted in both
the presence and absence of the AlkB protein, with all of the
necessary cofactors. Figure 3 shows representative MS spectra
corresponding to each oligonucleotide containing an exocyclic
dG lesion before and after AlkB treatment. The molecular
weight (MW) of each of the 16-mer oligonucleotides employed
was calculated, from which the −4 charge monoisotopic mass
(all 12C, 14N, etc.) was determined (Table 1). For example, the
MW of the 16-mer containing the α-OH-PdG lesion is 4960.88
(Da); therefore, its monoisotopic −4 charge state has a
theoretical m/z of 1239.21. In this case, an m/z of 1239.20 was
observed experimentally (Figure 3a), which correlated well with
the theoretical value (Table 1). Because the MS conditions
used throughout this study produced robust −4 charge states
for all the oligonucleotides analyzed, all of the m/z numbers
discussed below refer to −4 charge states, unless otherwise
speciﬁed. The chemical structures corresponding to the peaks
labeled in Figure 3 as well as their proposed AlkB-catalyzed
transformations are shown in Figure 4.
Interestingly, the mass spectrum of α-OH-PdG in the
absence of AlkB showed two peaks: a major peak at m/z
1239.20, which corresponds to the 16-mer containing the α-
Figure 2.MS/MS analysis of prototypic 16-mer oligonucleotide containing the AlkB-oxidized form of γ-OH-PdG. (Top) Predicted collision-induced
dissociation (CID) fragmentation pattern of the 16-mer oligonucleotide. X denotes the lesion or repair reaction intermediate or product. (Bottom)
MS/MS fragmentation spectrum of 16-mer containing the AlkB-oxidized form of γ-OH-PdG. A comparison of predicted and observed m/z values
for the MS/MS fragmentation pattern shown at the bottom of the ﬁgure is included in the Supporting Information (Table S6).
Figure 3. Q-TOF mass spectrometry analysis of reactants and
products of the oligonucleotides containing exocyclic guanine lesions
incubated with AlkB for 2 h. Data represent the −4 charge envelopes;
multiple ion mass peaks associated with each envelope reﬂect mostly
the number of 13C atoms in each −4 charge packet. The monoisotopic
peak (all 12C, 14N, etc.) value is labeled above each peak envelope. (a)
α-OH-PdG; (b) α-OH-PdG + AlkB; (c) γ-OH-PdG; (d) γ-OH-PdG +
AlkB; (e) M1dG; and (f) M1dG + AlkB.
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OH-PdG lesion (structure 1a, calculated m/z 1239.21), and a
minor peak at m/z 1234.70, which corresponds to a dehydrated
form of α-OH-PdG (structure 2, calculated m/z 1234.71)
(Figures 3a and 4a). The chemical structure of 2 was conﬁrmed
by MS/MS fragmentation analysis (Figures S10−S11 and
Tables S2−S3). Upon addition of AlkB protein, two new
products were observed with m/z 1238.68 and 1243.18
(Figures 3b, S1a, and S2). The product with mass 1243.18
was assigned to the oxidized form of the parent α-OH-PdG
lesion (structure 3a, calculated m/z 1243.21), consistent with
the 4 m/z units increase, which in the −4 charge state
corresponds to 16 Da, the mass of an oxygen atom. The
product with mass 1238.68 is similarly 4 m/z units higher than
the dehydrated form at 1234.70, suggesting that it could be an
oxidized form of 2 (structure 4, calculated m/z 1238.71)
(Figures S1 and S2). However, structure 4 could also arise from
dehydration of the oxidized intermediate (structure 3a), being
4.5 m/z units lower than the 1243.18 species (which, in the −4
charge state, corresponds to the loss of a water molecule, 18
Da). These data suggest that, under these reaction conditions,
AlkB can oxidize the α-OH-PdG lesion (and its dehydrated
form), transforming it into the diol 3a that could spontaneously
lose the exocyclic bridge to restore the parental deoxyguanosine
(Figure 4a). However, the fully repaired deoxyguanosine
product was not observed, perhaps because the amount of
oxidized intermediate 3a formed was relatively small, with only
5.5% conversion (Table 3A).
The oligonucleotide containing γ-OH-PdG had an exper-
imental m/z of 1239.23 (structure 5a, calculated m/z 1239.21).
Incubation with AlkB resulted in the conversion of about 60%
of the γ-OH-PdG starting material into four new species
(Figure 3d and Table 2) with m/z values of 1225.17 (dG,
structure 6), 1243.17 (diol intermediate 3a), 1238.67 (single-
dehydration product 4), and 1234.17 (double-dehydration
product 7, M1dG). Relative mass diﬀerences between these
peaks (Figure S1b) were used to propose chemical structures
for all of the intermediates (Figure 4a), which were further
conﬁrmed by an MS/MS fragmentation analysis (Figures S12−
S14 and Tables S4−S6). The appearance of these intermediates
and products suggests the following reaction course for direct
Figure 4. Chemical structures and proposed pathways for AlkB-mediated exocyclic guanine lesions transformation: (a) α-OH-PdG (dotted border)
and γ-OH-PdG (solid border); (b) M1dG (dashed border).
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reversal of γ-OH-PdG damage: AlkB oxidizes the methylene
group adjacent to the N2-position of γ-OH-PdG to generate
α,γ-dihydroxy-PdG (3a), which can release MDA to form
undamaged guanine (6). The ﬁnal step of MDA release from
3a is analogous to the release of glyoxal from the εA glycol
intermediate that forms when AlkB repairs the εA lesion.46
However, intermediate 3a can also dehydrate to form 4 and,
upon loss of another water molecule, intermediate 7, which is
the MDA adduct M1dG (Figure 4a). As will be shown later,
M1dG is itself a substrate for AlkB oxidation. However, given
the small amounts M1dG formed in the reaction of γ-OH-PdG
with AlkB, the intermediates of the M1dG reaction with AlkB
likely were below the limit of detection and therefore were not
observed.
When the oligonucleotide containing M1dG (starting
material m/z of 1234.19) was incubated with AlkB under
similar conditions, four new mass envelopes were observed in
the mass spectrum (Figures 3f and S1c), besides the unreacted
starting material. These peaks suggested a reaction course for
direct reversal of M1dG damage by AlkB (Figure 4b).
Speciﬁcally, the mass envelope at m/z 1238.19 was consistent
with the AlkB-catalyzed formation of an epoxide for M1dG
(structure 8 in Figure 4b, calculated m/z 1238.20, Table 1).
Hydrolysis of the epoxide would generate glycol 9, observed at
m/z 1242.69, consistent with the calculated m/z 1242.71. The
additional species observed at m/z 1247.19 indicated the
presence of the trihydroxylated intermediate 10 (calculated m/z
1247.21), which would be the hydration product of glycol 9.
The spontaneous loss of 2-hydroxy-MDA from the trihydroxy-
lated intermediate 10 would generate the undamaged guanine
base, observed at m/z 1225.19 (calculated m/z 1225.21)
(Figures 3f and 4b). The assignment of intermediates was
conﬁrmed by MS/MS fragmentation analysis (Figures S15−
S17 and Tables S7−S9).
Exocyclic Guanine DNA Adducts Are Substrates for
AlkB in dsDNA. AlkB can repair alkylated nucleic acid bases in
both ssDNA and dsDNA. While repair in the single-stranded
context is typically more eﬃcient,60 there are examples of
lesions that are repaired by AlkB equally well in ssDNA and
dsDNA.61 Therefore, it was of interest to investigate whether
the acrolein- and MDA-derived exocyclic dG lesions were also
substrates for AlkB in dsDNA.
AlkB repair reactions were carried out with each of the three
exocyclic dG adducts opposite each of the four canonical bases
(T, C, G, and A) (Figures S3−S5). The amount of the starting
material converted by AlkB (Table 2) was estimated by
integrating the extracted ion chromatograms (EIC) of each
peak in the mass spectra (see Experimental Procedures for
details). Likewise, the relative amounts of the intermediates and
repair products formed in each case were also estimated (Table
3A−C). The data show that the eﬃciency of AlkB-mediated
oxidation of exocyclic dG adducts depended not only on the
type of lesion (as seen in ssDNA) but also on the nature of the
base placed opposite the lesion. In general, the oxidation was
less eﬃcient in dsDNA compared with that in ssDNA, with
M1dG being a notable exception, for which the maximum
conversion of starting material was observed in dsDNA when
placed opposite T (Table 2). As a general trend, lesions were
more eﬃciently converted when placed opposite T than
opposite any other base. The smallest conversion was observed
when lesions were placed opposite C (Table 2).
The quantiﬁcation of intermediates and fully repaired
product for each of the AlkB reactions above provided some
additional insights. For γ-OH-PdG, the AlkB conversion was at
least 3-fold lower in dsDNA compared with that in ssDNA, and
the amount of diol intermediate (structure 3a) formed in the
dsDNA reaction was reduced by a similar amount. However,
the amount of fully repaired product, dG, was disproportionally
reduced (by at least 10-fold with respect to ssDNA, Table 3B),
indicating that the ﬁnal step of MDA release from 3a is
impeded when AlkB repair occurs in dsDNA. For M1dG
opposite T, the AlkB conversion was higher in dsDNA than
that in ssDNA. However, the amount of fully repaired product
was maximal in ssDNA (8.1%) compared with that in dsDNA
(1.3−4.6%) (Table 3C), suggesting, as before, that the ﬁnal
step of the release of the oxidized exocyclic bridge from
intermediate 10 was impeded in dsDNA. For α-OH-PdG in
dsDNA, AlkB oxidation was even less eﬃcient than that in
ssDNA, with the oxidized intermediates detected at corre-
spondingly lower levels (Table 3A). Just as in ssDNA, no fully
repaired dG product was observed in the AlkB reaction of α-
OH-PdG in dsDNA. However, it appears that the equilibrium
between the hydrated (structure 1a) and dehydrated (structure
2) forms of α-OH-PdG shifted toward the structure 1a in
dsDNA.
Cytosine Opposite Exocyclic Guanine Adducts Sta-
bilizes Duplex DNA. The reactions of AlkB with dsDNA
consistently showed that when the acrolein- and MDA-derived
exocyclic dG adducts were placed opposite C the eﬃciency of
repair was signiﬁcantly diminished (Table 2). We hypothesize
that this eﬀect was due to the ability of exocyclic dG lesions to
exist in open-ring structures.62−64 In the case of γ-OH-PdG63
and M1dG,
64 the presence of the cognate base pairing partner
(dC) in the opposite strand has been shown to induce the
opening of the exocyclic ring to expose the Watson−Crick
base-pairing side of the damaged guanine and allow it to form
hydrogen bonds. To test this hypothesis in our sequence
context, the thermal melting temperatures (Tm) of the
oligonucleotides containing exocyclic dG adducts opposite all
four canonical bases were measured (Table 4). Consistent with
this hypothesis and previous observations,63,64 the melting
temperatures containing γ-OH-PdG and M1dG opposite C
were the highest in each case (as compared to other
complementary bases) and approached the Tm of a duplex
containing a canonical G:C base pair at the lesion site. When
compared with a normal guanine, the presence of M1dG
increased the melting temperature of the duplex when opposite
T, G, or A. This eﬀect was likely due to the extended aromatic
ring system of M1dG, which allowed for additional favorable
stacking interactions. By contrast with the other two lesions, the
oligonucleotide containing α-OH-PdG was not stabilized
opposite any of the four canonical bases. This observation
was consistent with the fact that the open-ring structure of α-
OH-PdG would allow only the N2 position of guanine to
Table 4. Melting Temperature of Oligonucleotides
Containing α-HOPG, γ-HOPG, M1dG, or G Annealed to a
Complementary Strand Containing C, T, G, or A Opposite
the Lesion Site
oligonucleotides C T G A
G 63.6 ± 0.3 57.1 ± 0.2 54.1 ± 0.3 56.5 ± 0.3
α-HOPG 53.0 ± 0.5 49.8 ± 0.2 53.4 ± 0.2 52.8 ± 0.7
γ-HOPG 59.0 ± 0.3 54.5 ± 0.3 55.0 ± 0.3 54.0 ± 0.3
M1dG 62.2 ± 0.3 60.1 ± 0.3 56.6 ± 0.2 56.6 ± 0.2
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interact with the opposite base, while the N1 position would be
still blocked.
PFBHA Trapping Reveals Open-Ring Forms of
Exocyclic Guanine DNA Lesions. The γ-OH-PdG62,63,65
and M1dG
66−69 lesions have been reported to equilibrate
between ring-closed and ring-open forms. In dsDNA, γ-OH-
PdG predominantly exists in open-ring form when placed
opposite dC,63 whereas in ssDNA, it exists mostly in the closed-
ring form. In both cases, γ-OH-PdG could be trapped by
peptides, with the conjugation being more eﬀective in dsDNA
than in ssDNA.65 The reversible, hydrolytic ring-opening of
M1dG has also been well-studied,
66−68,64 with the ring-open
form of M1dG predominating in dsDNA when M1dG is placed
opposite dC.64,66
The presence of open-ring forms of the three exocyclic dG
lesions was studied in our sequence context by incubating the
site-speciﬁcally modiﬁed oligonucleotides used in the AlkB
repair studies with O-(2,3,4,5,6-pentaﬂuorobenzyl)-
hydroxylamine (PFBHA), a nucleophilic alkoxyamine that
forms stable oxime linkages with free aldehydes.50 After 1 h
at room temperature, the reaction mixtures were analyzed using
high-resolution MS (Figure 5). The calculated and exper-
imentally observed m/z values for the oligonucleotides trapped
with PFBHA are listed in Table S1.
All three oligonucleotides containing the exocyclic dG lesions
were trapped by PFBHA, indicating that they can potentially
exist in open-ring forms containing free aldehyde groups
(Figure 5). In the case of γ-OH-PdG, PFBHA trapping
provides strong evidence that the exocyclic adduct (5a) exists
in equilibrium with an open-ring aldehyde form (5b). For
M1dG (7), however, the complete trapping with PFBHA does
not unequivocally demonstrate the existence of the ring-open
aldehyde forms (11b or 12b), because PFBHA can react
directly with the closed-ring form of M1dG and generate the
oxime product without the formation of a free aldehyde. This
alternative course of reaction is based on the observation that
the rate of ring opening of M1dG at neutral pH in water is
slower than the rate of trapping of M1dG with hydroxylamine.
70
The presence of PFBHA completely trapped the oligonu-
cleotide containing γ-OH-PdG and M1dG. The parent peak of
γ-OH-PdG at m/z 1239.21 (calculated m/z 1239.21) shifted
quantitatively to a PFBHA-trapped species at m/z 1287.97
(calculated m/z 1287.97). Similarly, the parent peak of M1dG
at m/z 1234.20 (calculated m/z 1234.21) was completely
converted to a PFBHA-trapped species at m/z 1287.47
(calculated m/z 1287.46). In the case of α-OH-PdG, 1a
(observed m/z 1239.20, calculated m/z 1239.21) can form an
open-ring structure (1b) that can be trapped with PFBHA.
However, as described previously, 1a is also in equilibrium with
the imine 2, which could also react with PFBHA to give a
trapped product. Only a partial trapping of the α-OH-PdG was
observed (PFBHA-trapped species at m/z 1287.98, calculated
m/z 1287.97), with the relative amounts of untrapped
oligonucleotides suggesting that PFBHA reacted primarily
with 1b and not with 2. Assuming PFBHA trapping of 1b is
fast, these data also suggest that the formation of the open-ring
form of α-OH-PdG is slower than that for γ-OH-PdG.
The Exocyclic dG Adducts Reduced with NaBH4 Are
Also Substrates for AlkB. Given the presence of the open-
ring forms of the three exocyclic dG lesions, it was of interest to
investigate whether AlkB could also act on the open-ring forms.
Sodium borohydride (NaBH4) buﬀered with sodium phosphate
was used to lock the open-ring forms by reducing the open-ring
aldehydes to alcohols,71 which were detected using high-
resolution MS (Figure 6). For γ-OH-PdG, upon treatment with
NaBH4, the parent peak at m/z 1239.23 was quantitatively
converted to a new peak at m/z 1239.71, consistent with the
addition of two hydrogens. Because there are no functional
groups reducible by NaBH4 in the closed-ring structure of γ-
OH-PdG, or on any other normal base, the peak at m/z
1239.71 must correspond to the open-ring alcohol of γ-OH-
PdG, structure 16 (calculated m/z 1239.72) (Figures 6b and
S7). Similarly, when the oligonucleotide containing α-OH-PdG
was treated with NaBH4, the parent peak at m/z 1239.16
shifted to m/z 1239.67 (Figures 6a and S6). Similar to the
argument made for γ-OH-PdG, the only functional group that
could be reduced by NaBH4 is the aldehyde of the open-ring
form of α-OH-PdG (structure 1b, Figure 4a) to generate an
open-ring alcohol (structure 19, calculated m/z 1239.67). The
dehydrated form of α-OH-PdG (structure 2), a cyclic imine,
was also reduced by NaBH4, as suggested by the change in the
isotopic distribution pattern and the expansion of the peak
envelope toward higher masses (Figure 6a). These changes are
consistent with the appearance of a peak at m/z 1235.16
(Figures 6a and S6), which presumably corresponded to a fully
saturated 1,N2-propano-dG (structure 15, calculated m/z
1235.21) (Figure 6a). Both reduction products (19 and 15)
are consistent with the reported NaBH4 reduction of the α-
OH-PdG free nucleoside.54 Additional evidence for the
formation of 15 was obtained by running the NaBH4 reaction
at a lower pH (5.8 instead of 7.0), which improved the yield of
reduction of 2 (Figure S9). However, even at low pH,
reduction of 2 was not quantitative, perhaps due to the lesser
reactivity of the aromatically stabilized cyclic imine toward
NaBH4 compared to that of an aldehyde.
When exposed to NaBH4, the M1dG-containing oligonucleo-
tide (observed m/z 1234.19, calculated m/z 1234.21) was
converted to a reduced species detected at m/z 1234.70
Figure 5. Q-TOF mass spectrometry analysis of the PFBHA trapping
reactions of oligonucleotides containing exocyclic guanine lesions.
Data represent the −4 charge envelopes, as described in Figure 3. (a)
α-OH-PdG; (b) α-OH-PdG + PFBHA; (c) γ-OH-PdG; (d) γ-OH-
PdG + PFBHA; (e) M1dG; and (f) M1dG + PFBHA.
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(Figures 6c and S8). This product has been previously reported
to be structure 18 (Figure 6c).72,73 The reduced ring-open form
of M1dG requires the initial addition of a water molecule to
produce 11a or 12a (calculated m/z 1238.71) (Figure 4b),
which could subsequently be reduced with NaBH4. However,
the open-ring form of M1dG is known to enolize readily and
thus is not very reactive toward NaBH4.
74 Consistent with this
fact, a product with an m/z of 1239.21 corresponding to a
reduced version of 11a or 12a could not be detected (Figures
6c and S8); therefore, under the reaction conditions, M1dG
could not be trapped as an open-ring species by NaBH4.
Nevertheless, the reaction of AlkB with the reduced form of
M1dG provided additional insights into the regioselectivity of
the AlkB repair reactions on exocyclic dG structures.
After NaBH4 treatment, the oligonucleotides were ﬁrst
puriﬁed using Sephadex G-50 columns to remove excess
NaBH4 and other salts and were then allowed to react with
AlkB under the same conditions as those previously described.
Figure 6. Q-TOF mass spectrometry analysis of the reactions of oligonucleotides containing exocyclic guanine lesions with NaBH4 and the
subsequent incubation of the reduced forms with AlkB for 2 h. Each peak is labeled with its monoisotopic m/z value, in the −4 charge state. The
corresponding chemical structures and proposed transformations are included next to each set of mass spectrometry ion traces. (a) (Top) α-OH-
PdG, (Middle) α-OH-PdG + NaBH4, (Bottom) α-OH-PdG + NaBH4 + AlkB. (b) (Top) γ-OH-PdG, (Middle) γ-OH-PdG + NaBH4, (Bottom) γ-
OH-PdG + NaBH4 + AlkB. (c) (Top) M1dG, (Middle) M1dG + NaBH4, (Bottom) M1dG + NaBH4 + AlkB.
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AlkB produced more fully repaired product (dG) when
incubated with NaBH4-treated lesions as compared to the
incubations with untreated lesions. For α-OH-PdG, these
reaction conditions produced detectable levels of fully repaired
dG (6). The amount of the reduced open-ring alcohol 19 did
not change upon treatment with AlkB, whereas the amount of
15 was diminished in the AlkB reaction (Figure 6a). These
observations indicated that the fully repaired dG was not
generated from the reduced open-ring form 19, but rather from
the 1,N2-propano-dG reduced intermediate (15) via two
successive oxidations by AlkB, which would generate 3a
(Figure 6a).
For the reduced ring-open form of γ-OH-PdG (16), the AlkB
reaction intermediates were consistent with oxidation at the
carbon attached to the N2 position of guanine with subsequent
release of a three-carbon aldehyde to generate fully repaired dG
(Figure 6b). This reaction was very eﬃcient, with most of the
starting material being consumed along with a high yield
(∼50%) of dG. For NaBH4-treated M1dG, the AlkB reaction
generated several intermediates (Figure 6c), consistent with
oxidation of 18 at the carbon attached to the N2 position of
guanine to generate 12a, which upon dehydration yielded the
original M1dG lesion (structure 7, observed m/z 1234.23).
Subsequently, M1dG (7) reacted with AlkB, as shown before
(Figures 3f and 4b), to generate epoxide 8, triol 10, and, upon
spontaneous loss of 2-hydroxy-MDA, the fully repaired
product, dG. In an alternative reaction course, 18 could react
with AlkB to generate epoxide 20 and upon hydration, diol 21
(Figure 6c). Subsequently, 21 can be further oxidized by AlkB
to generate triol 10, leading to additional repair product dG.
These additional reaction pathways could explain the improved
yield of fully repaired product, dG, when NaBH4-treated M1dG
was incubated with AlkB.
■ DISCUSSION
The three exocyclic dG lesions investigated (i.e., α-OH-PdG, γ-
OH-PdG, and M1dG) are important biomarkers of exposure to
ubiquitous environmental chemicals5 and inﬂammation-in-
duced lipid peroxidation byproducts,13,14,37 acrolein and
MDA. The present study demonstrates that the exocyclic dG
lesions are processed by AlkB by a complex but chemically
understandable biochemical pathway. Among the three lesions
studied in ssDNA, γ-OH-PdG was repaired most eﬃciently,
followed by M1dG and α-OH-PdG (Table 2 and Table 3A−C).
The overall AlkB eﬃciency at repairing the lesions was
generally lower in dsDNA than that in ssDNA, as evidenced
by the lower amounts of fully repaired product formed in each
case (Table 3A−C). However, in the one case, when M1dG was
opposite T, the total amount of starting material consumed was
higher than in the incubation of AlkB with M1dG in ssDNA.
The base placed opposite the lesion also inﬂuenced the repair
reactions. Generally, when the lesions were placed opposite T,
the repair was most eﬃcient, with C being the opposite base
that gave the lowest conversions (Tables 2 and 3A−C). These
observations can be rationalized by the base-ﬂipping mecha-
nism proposed for AlkB,75 in which a mispaired base (i.e.,
lesion opposite T) is more likely to splay out into the enzyme
active site to be repaired. By contrast, when the exocyclic dG
lesions are placed opposite C, a “correct base pair” is formed
(in the case of γ-OH-PdG and M1dG, via their open-ring
forms), which hinders base-ﬂipping, eﬀectively hiding the lesion
from AlkB and reducing the repair eﬃciency. This mechanism
is consistent with our previous study of AlkB activity on N2-dG
alkyl lesions,52 such as m2G, e2G, and the bulkier N2-furfuryl-
dG and N2-tetrahydrofurfuryl-dG, which are good AlkB
substrates in ssDNA but are poorly repaired when placed in
dsDNA opposite dC.52 Furthermore, the preference of AlkB for
repairing exocyclic dG lesions in ssDNA suggests that
transcriptionally active regions of the genome are likely to be
most protected by AlkB activity, which complements other
repair pathways that target exocyclic dG lesions only in dsDNA
contexts (i.e., NER).23
All three exocyclic dG lesions studied have been proposed to
exist in equilibrium with open-ring forms.33,62,63 The trapping
of the α-OH-PdG and γ-OH-PdG with PFBHA (Figure 5)
suggests that there is a low but kinetically useful concentration
of the ring-opened aldehyde form in equilibrium with the
closed-ring form. Subsequently, by using NaBH4 to reduce the
aldehydes and trap the open-ring forms of α-OH-PdG and γ-
OH-PdG, the activity of AlkB on the open-ring forms was also
investigated. N2-(3-Hydroxypropyl)-G, the NaBH4-reduced
open-ring form of γ-OH-PdG, was shown to be a good
substrate for AlkB repair, even better than the closed-ring γ-
OH-PdG substrate (Figure 6b). The reduced open-ring form of
α-OH-PdG, N1-(3-hydroxypropyl)-G, was not signiﬁcantly
oxidized by AlkB; instead, the reduced version of the
dehydrated α-OH-PdG, 1,N2-propano-dG (structure 15),
reacted with AlkB (Figure 6a).
For M1dG, however, the PFBHA trapping does not
necessarily support the existence of the ring-opened aldehyde
form, because the trapped product can also be formed by a
direct reaction of PFBHA amine at the carbon adjacent to N1
of M1dG.
64,74 Consistent with this argument, M1dG incubation
with NaBH4 did not generate a measurable amount of trapped
open-ring forms; the reduction yielded the closed-ring product
18, which was also a good substrates for AlkB, on par with the
parent species M1dG. Taken together, the trapping experiments
demonstrated that AlkB can process both open-ring species
(such as the open-ring of γ-OH-PdG) and closed-ring species
(such as the ones derived from M1dG). However, due to
equilibria between open- and closed-ring forms, the AlkB repair
reactions of exocyclic dG lesions are complex, involving
overlapping pathways with multiple convergence points (Figure
4).
Given the complexity of the repair pathways (Figure 4), it is
challenging to establish unambiguously which reaction pathway
(i.e., oxidation of open- or closed-ring intermediates) is
predominant. Speciﬁcally, is AlkB processing the exocyclic dG
lesions by directly oxidizing the closed-ring forms or is AlkB
reacting primarily with the open-ring forms, essentially simpler
N1- and N2-alkyl guanines that are known to be AlkB
substrates? For α-OH-PdG, the data were more consistent
with the AlkB oxidation on the closed-ring form. When this
substrate was reduced to the open-ring form with NaBH4, no
corresponding AlkB oxidation intermediate was detected; the
AlkB reaction presumably occurred only with the reduced
dehydrated version of α-OH-PdG (structure 2), which is a
closed-ring form (Figure 6a). A possible explanation for this
preference may be that the open-ring form of α-OH-PdG
generated a bulky alkyl group on the N1 position of guanine,
which did not ﬁt in the active site of AlkB, unlike a smaller N1-
methyl-dG substituent, which is repaired by AlkB.51
For γ-OH-PdG, the data suggest that both the closed- and
open-ring forms could be substrates for AlkB. We demon-
strated that AlkB more eﬃciently repaired the reduced, open-
ring form of γ-OH-PdG than the unreduced, closed-ring γ-OH-
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PdG lesion. This observation is consistent with previous work,
which demonstrated that AlkB can repair guanines substituted
at N2 positions with alkyl groups of varying sizes, including
bulky alkyl substitutents.52 It is noted, however, that the
observed repair of the open-ring form does not rule out the
possibility that AlkB can additionally oxidize the closed-ring
form of γ-OH-PdG (i.e., the 5a to 3a step of Figure 4a).
The data on the AlkB repair of M1dG lesion are most
consistent with the formation of an epoxide intermediate (8) of
the closed-ring form, which subsequently gets hydrated twice to
form triol 10. Intermediate 10 can also be obtained from the
oxidation and hydration of intermediates 11a or 12a, which are
hydrated forms of M1dG. However, the presence of these
hydrated forms was not detectable in the starting material, and
their reduced forms were not observed in the NaBH4 reaction
(Figure 6c). Therefore, the alternative pathways involving 11a
and 12a are expected to play a minor role, if any, in the AlkB
reaction (Figure 4b). The data on M1dG repair by AlkB suggest
that the enzyme, similar to its mechanism on εA, primarily acts
on the closed-ring form of the substrate.
The AlkB repair data on exocyclic dG lesions also provided
some insight on the AlkB selectivity between oxidation at N1-
or N2-attached carbons, in the context of an exocyclic propano
adduct. By placing the three-carbon exocycle into a published
AlkB structure,75 it was determined that the exocyclic carbon
atoms adjacent to the N1 and N2 positions are situated at
similar distances relative to the iron center of AlkB (Figure
S19). This suggests that AlkB, in principle, should oxidize an
exocyclic propano adduct equally well at either the N1 or N2
position. However, in the present study, AlkB repaired the two
OH-PdG lesions with very diﬀerent eﬃciencies (Table 2), with
γ-OH-PdG being repaired more eﬃciently than α-OH-PdG.
One explanation for the diﬀerent AlkB reactivity toward these
isomeric lesions may be the propensity to form open-ring
species. The open-ring form of α-OH-PdG shifts the entire
alkyl substituent to the N1 position, which likely cannot be
accommodated in the AlkB active site; by contrast, the open-
ring form of γ-OH-PdG contains the alkyl substituent at N2,
which can swivel away from the protein to potentially reduce
steric clashes. On the basis of these considerations, we speculate
that the most likely reaction course of the fully reduced
exocyclic propano-dG (16) with AlkB involves oxidations ﬁrst
at the N1 carbon (γ-position) and subsequently at the N2
carbon (α-position) to generate the fully repaired dG.
Compared with other known exocyclic AlkB substrates, such
as εA and EA, the acrolein- and MDA-derived dG lesions are
repaired less eﬃciently under similar conditions.46,49,50 One
possible explanation is that three-carbon bridges are bulkier
than two-carbon bridges and some of them (i.e., α-OH-PdG, γ-
OH-PdG) can form puckered structures that are harder to
accommodate in the active site of the enzyme. Furthermore, the
position of a three-carbon exocycle between N1 and N2 of
guanine could be suboptimal in the AlkB active site compared
with the two-carbon bridge between N6 and N1 of adenine.
Finally, AlkB has been demonstrated to prefer alkylated
adenines compared to alkylated guanines; speciﬁcally, N1-
methyl-adenine is repaired signiﬁcantly more eﬃciently than
N1-methyl-guanine.51 This diﬀerence in reactivity is believed to
be due to the fact that N1-methyl-adenine has a positive charge
on N1, whereas N1-methyl-guanine is a neutral species.
Maciejewska et al. proposed that, in general, the preference
of AlkB toward positively charged lesions is likely due to the
presence of negatively charged aspartate residue (Asp-135) in
the active site.53 Therefore, it is not surprising that this trend
extends to exocyclic alkyl lesions, where the exocyclic guanines
in the present study are repaired less eﬃciently by AlkB than
exocyclic adenines, in part because they are neutral species.
Furthermore, the higher repair eﬃciency of AlkB when acting
on positively charged lesions could also be explained by the
propensity of the AlkB oxidation intermediates of such lesions
to decompose and generate the fully repaired base.
Consequently, it is anticipated that AlkB oxidation intermedi-
ates with pKa’s of the base nitrogens altered in a direction that
favors protonation would convert more eﬃciently to the fully
repaired product. However, in the case of the exocyclic dG
lesions, the AlkB oxidation intermediates are generally more
abundant than fully repaired dG, suggesting that the pKa’s of
the N1 or N2 nitrogen of the intermediates are not altered
signiﬁcantly during the AlkB reactions.
The present work established the chemical competence of
the E. coli dioxygenase AlkB to oxidize and repair acrolein- and
MDA-derived exocyclic guanine lesions, suggesting that one
role of AlkB may be to alleviate the mutagenic and toxic
consequences of reactive aldehydes derived from these primary
toxicants. Additionally, the ability of AlkB to repair the open-
ring forms of exocyclic guanine lesions suggests that AlkB may
also modulate the toxicity and mutagenicity associated with the
formation of inter- and intrastrand cross-links30−33 generated
by the open-ring forms of the acrolein- and MDA-derived
exocyclic guanine lesions. Given that AlkB has nine mammalian
homologues76,77 (ABH1−8, FTO), it is anticipated that these
repair pathways may also be operating in mammalian cells;
however, the extent to which these pathways play a role in
modulating the mutagenic and carcinogenic risk associated with
exposure to acrolein and inﬂammation-derived MDA is not
known and remains to be established.
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